ster

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry
Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry
ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
Read All Our News >

Pharma News

AbbVie’s Mavyret shortens treatment period for some hep C patients
Repeat violations stack up at Dr. Reddy’s cancer drug plant
EMA recommends fexinidazole, the first all-oral treatment for sleeping sickness
Read All Pharma News >

New Products &Services

Therapeutical Diversity library
Cardiovascular library
CNS MPO library
RNA Trinucleotide mimetics